Year: 2008
Type: review
Abstract: have written comprehensively on neuroendocrine dysfunction in polycystic ovary syndrome (PCOS) in the recent literature, but have made several assertions which I find difficult to tie in with the current knowledge base.In this critique, I therefore focus on the three areas of disagreement below and argue the case for a more satisfactory explanation of these three issues based on the evidence available to us today and studies from our group. The Relationship Between Luteinizing Hormone (LH) and HyperandrogenismBlank et al 2 state that "...the concomitant disruption of neuroendocrine function would serve to further exacerbate hyperandrogenaemia..." and this is also depicted in their schema. 1,2Therefore, in their reviews they tend to imply that LH excess worsens hyperandrogenism through ovarian stimulation of androgenesis.This is unlikely to be valid despite the fact that a major neuroendocrine component of PCOS involves alterations in LH secretion, and primary LH excess has long been considered the cause of the excess ovarian androgen secretion in PCOS.This concept simply arose because of the known stimulatory effect of LH on theca cell function and the elevation of serum LH levels at baseline and in response to gonadotrophin releasing hormone (GnRH) in classic PCOS.Such a primary role of LH excess is arguable, however.Theca cells from polycystic ovaries secrete abnormal amounts of steroids in culture, both before and after LH stimulation.
Source: Clinical Medicine & Research
DOI: 10.3121/cmr.2008.796
Author: S. A. R. Doi
Institutions: Mubarak Al Kabeer Hospital, Kuwait University
Language: English
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W2156117606
